Cytokinetics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $7.70 billion, with shareholders equity totaling $-321.17 million.
The company employs approximately 235 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Cytokinetics Inc. reported $113.29 million in revenue, generating net income of $-777.89 million.
Key financial metrics include a P/E ratio of -9.90, a price-to-book (P/B) ratio of -23.98, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker CYTK.